UK and Russian ministers witness GSK/Binnopharm strategic deal signing
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and Russia's biopharmaceutical company Binnopharm, part of the Sistema financial corporation, have signed strategic alliance covering the supply and manufacture of several GSK vaccines and the development of manufacturing capability by Binnopharm. The collaboration is in line with the recently announced Russian government's policy to expand local production of innovative pharmaceuticals and biopharmaceuticals and reduce their imports (scripintelligence.com, 18 September 2009).